Individual Patient Esmethadone (REL-1017) Expanded Access Program

Summary

To provide expanded access of esmethadone (REL-1017) to patients with a serious or immediately life-threatening disease or condition that may potentially benefit from esmethadone (REL-1017) who do not have access to other effective therapy and are not eligible for other clinical trials with esmethadone (REL-1017).

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications